Analysts Set Revolution Medicines, Inc. (NASDAQ:RVMD) PT at $36.00

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1 year […]

Leave a Reply

Your email address will not be published.

Previous post Corteva, Inc. (NYSE:CTVA) Given Average Rating of “Moderate Buy” by Brokerages
Next post Russian factory activity humming – survey